Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases
Frontiers in Cell and Developmental Biology · 16.03.2023 · 11
DOI: 10.3389/fcell.2023.1148768 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 16.03.2023. Verfasst von Shivan Barungi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Jaén, Jaén, Spain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Jaén.
Abstract (Originalsprache)
Cardiovascular diseases (CVD) are the leading causes of death and disability in the world. Among all CVD, the most common is coronary artery disease (CAD). CAD results from the complications promoted by atherosclerosis, which is characterized by the accumulation of atherosclerotic plaques that limit and block the blood flow of the arteries involved in heart oxygenation. Atherosclerotic disease is usually treated by stents implantation and angioplasty, but these surgical interventions also favour thrombosis and restenosis which often lead to device failure. Hence, efficient and long-lasting therapeutic options that are easily accessible to patients are in high demand. Advanced technologies including nanotechnology or vascular tissue engineering may provide promising solutions for CVD. Moreover, advances in the understanding of the biological processes underlying atherosclerosis can lead to a significant improvement in the management of CVD and even to the development of novel efficient drugs. To note, over the last years, the observation that inflammation leads to atherosclerosis has gained interest providing a link between atheroma formation and oncogenesis. Here, we have focused on the description of the available therapy for atherosclerosis, including surgical treatment and experimental treatment, the mechanisms of atheroma formation, and possible novel therapeutic candidates such as the use of anti-inflammatory treatments to reduce CVD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, University of Jaén, Jaén, Spain.
- San Cecilio University Hospital of Granada, Granada, Spain.
- Tissue Establishment, Centro de Transfusión de Tejidos y Células, Córdoba, Spain.
- Centre for Biomedical Research (CIBM), Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, Granada, Spain.
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
- Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.
Förderung
- Universidad de Jaén
Zitieren
APA
Barungi, S., Hernández-Camarero, P., Moreno-Terribas, G., Villalba-Montoro, R., Marchal, J. A., López-Ruiz, E., & Perán, M. (2023). Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1148768
Vancouver
Barungi S, Hernández-Camarero P, Moreno-Terribas G, Villalba-Montoro R, Marchal JA, López-Ruiz E, et al. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1148768
BibTeX
@article{Barungi2023,
author = {Barungi, Shivan and Hernández-Camarero, Pablo and Moreno-Terribas, Gerardo and Villalba-Montoro, Rafael and Marchal, Juan Antonio and López-Ruiz, Elena and Perán, Macarena},
title = {Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1148768}
}
EUVIMED